Inventor
FONTENEAU JEAN-FRANÇOIS
FR3 patents
Patents
3 patentsUS10314905B2Jun 11, 2019
Use of a genetically modified infectious measles virus with enhanced pro-apoptotic properties (MV-deltaC virus) in cancer therapy
PASTEUR INSTITUT1 citations68
US9889193B2Feb 13, 2018
Use of a genetically modified infectious measles virus with enhanced pro-apoptotic properties (MV-deltaC virus) in cancer therapy
PASTEUR INSTITUT2 citations68
US10980873B2Apr 20, 2021
Use of a genetically modified infectious measles virus with enhanced pro-apoptotic properties (MV-deltaC virus) in cancer therapy
PASTEUR INSTITUT0 citations58